Identification of a CD21 receptor-deficient, non-Ig-secreting peripheral B lymphocyte subset in HIV-seropositive drug abusers - PubMed (original) (raw)
Identification of a CD21 receptor-deficient, non-Ig-secreting peripheral B lymphocyte subset in HIV-seropositive drug abusers
A Benedetto et al. Clin Immunol Immunopathol. 1992 Feb.
Abstract
We have studied 61 HIV-seropositive heroin addicts (18 asymptomatic, 20 ARC, and 23 AIDS cases), 26 HIV-seronegative heroin addicts, and 45 healthy blood donors, matching the groups each other for age and sex. We have focused on the phenotypic characteristics of B subpopulations in the peripheral blood of HIV-seropositive and -seronegative drug abusers, paying particular attention to the consistence of the "CD20+" B cell subset, which poorly expresses the CD21 membrane receptor for the C3d and Epstein-Barr virus (EBV) (referred to as "CD20 + CD21-" subset). In healthy blood donors, the ratio CD20 + CD21-/CD20+ x 100 is extremely low (mean +/- SEM = 8.1 +/- 0.9) and rarely exceeds the value of 20. On the contrary, in HIV seropositives, the values are much more dispersed, with higher mean values (mean +/- SEM = 25.8 +/- 1.8) ranging from 50 to 60. An intermediate situation characterizes the class of HIV-seronegative heroin addicts, whose values are slightly higher and more dispersed than that of normal controls (mean +/- SEM = 11.6 +/- 1.3). The extent of the amplification of the CD20 + CD21- subset in HIV-seropositive individuals does not apparently correlate with the progression of the disease and represents an early event in the clinical course of HIV infection. For each subject of the study group, the number of CD20 + CD21- B lymphocytes is not correlated to other early markers of HIV infection, as the T4 lymphocyte number, or total Ig levels in sera. A functional characterization of the CD20 + CD21- B cell subset indicates that, in HIV-seropositive patients, these cells are unable to produce specific and nonspecific immunoglobulins (Ig's), either spontaneously or after pokeweed mitogen stimulation. Furthermore, this cell subset is characterized by poor expression of surface Ig's. The data reported suggest that this cell subset can be regarded as situated at an early level of B cell lineage differentiation.
Similar articles
- The CR2 receptor (CD21) shows increased expression in the more differentiated cells of an antigen-specific B cell line.
Pillemer SR, Tsokos GC, Barbieri SA, Balow JE, Golding B. Pillemer SR, et al. Cell Immunol. 1990 Feb;125(2):386-95. doi: 10.1016/0008-8749(90)90093-7. Cell Immunol. 1990. PMID: 1688740 - Low expression of CD20 and CD23 in Epstein-Barr virus-induced B cell tumors in SCID/hu mice.
Garnier JL, Cooper NR, Cannon MJ. Garnier JL, et al. Am J Pathol. 1993 Feb;142(2):353-8. Am J Pathol. 1993. PMID: 7679547 Free PMC article. - Phenotypic analysis of complement receptor 2+ T lymphocytes: reduced expression on CD4+ cells in HIV-infected persons.
June RA, Landay AL, Stefanik K, Lint TF, Spear GT. June RA, et al. Immunology. 1992 Jan;75(1):59-65. Immunology. 1992. PMID: 1371493 Free PMC article. - CD21 -/low B cells: A Snapshot of a Unique B Cell Subset in Health and Disease.
Thorarinsdottir K, Camponeschi A, Gjertsson I, Mårtensson IL. Thorarinsdottir K, et al. Scand J Immunol. 2015 Sep;82(3):254-61. doi: 10.1111/sji.12339. Scand J Immunol. 2015. PMID: 26119182 Review. - Structure and function of the B-lymphocyte Epstein-Barr virus/C3d receptor.
Nemerow GR, Moore MD, Cooper NR. Nemerow GR, et al. Adv Cancer Res. 1990;54:273-300. doi: 10.1016/s0065-230x(08)60814-3. Adv Cancer Res. 1990. PMID: 2136962 Review. No abstract available.
Cited by
- HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals.
Moir S, Malaspina A, Ogwaro KM, Donoghue ET, Hallahan CW, Ehler LA, Liu S, Adelsberger J, Lapointe R, Hwu P, Baseler M, Orenstein JM, Chun TW, Mican JA, Fauci AS. Moir S, et al. Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10362-7. doi: 10.1073/pnas.181347898. Epub 2001 Aug 14. Proc Natl Acad Sci U S A. 2001. PMID: 11504927 Free PMC article. - B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells.
Moir S, Malaspina A, Li Y, Chun TW, Lowe T, Adelsberger J, Baseler M, Ehler LA, Liu S, Davey RT Jr, Mican JA, Fauci AS. Moir S, et al. J Exp Med. 2000 Sep 4;192(5):637-46. doi: 10.1084/jem.192.5.637. J Exp Med. 2000. PMID: 10974030 Free PMC article. - Association of phenotypic changes in B cell lymphocytes and plasma viral load in human immunodeficiency virus-infected patients.
Dawood MR, Conway B, Patenaude P, Janmohamed F, Montaner JS, O'Shaughnessy MV, Hammond GW. Dawood MR, et al. J Clin Immunol. 1998 May;18(3):235-40. doi: 10.1023/a:1020539207593. J Clin Immunol. 1998. PMID: 9624583 - Enhancing role of complement in HIV infection.
Mouhoub A, Thieblemont N, Delibrias C, Fischer E, Kazatchkine MD. Mouhoub A, et al. Clin Exp Immunol. 1994 Aug;97 Suppl 2(Suppl 2):9-11. doi: 10.1111/j.1365-2249.1994.tb06255.x. Clin Exp Immunol. 1994. PMID: 8070143 Free PMC article. Review. No abstract available.